Năm ngoái, Smith & Nephew PLC đã tạo ra 1.07B USD từ mảng kinh doanh hoạt động hiệu quả nhất của mình là Sports Medicine Joint Repair. Khu vực United States of America đóng góp lớn nhất, mang lại 3.31B USD trong năm qua. Trong quý gần nhất, Smith & Nephew PLC đã ghi nhận doanh thu 300.00M USD cho kỳ kết thúc vào ngày 2026-06-27, đến từ mảng kinh doanh hoạt động hiệu quả nhất là Advanced Wound Care. Khu vực United States of America đóng góp mức doanh thu cao nhất, đạt 816.00M USD.

Theo Doanh nghiệp

Doanh thu

Tỷ trọng

Hàng năm

Hàng năm

Hàng quý

Sports Medicine Joint Repair

Knee Implants

Advanced Wound Care

Trauma & Extremities

Arthroscopic Enabling Technologies

Hip Implants

Advanced Wound Bioactives

Advanced Wound Devices

ENT (Ear, Nose and Throat)

Other Surgical Businesses

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Sports Medicine Joint Repair

1.07B(17.31%)

982.00M(16.90%)

945.00M(17.03%)

870.00M(16.68%)

839.00M(16.10%)

710.00M(15.57%)

794.00M(15.45%)

697.00M(14.21%)

Knee Implants

1.01B(16.40%)

947.00M(16.30%)

940.00M(16.94%)

899.00M(17.24%)

876.00M(16.81%)

822.00M(18.03%)

1.04B(20.28%)

1.02B(20.74%)

Advanced Wound Care

766.00M(12.43%)

735.00M(12.65%)

725.00M(13.07%)

712.00M(13.65%)

731.00M(14.03%)

647.00M(14.19%)

714.00M(13.90%)

740.00M(15.09%)

Trauma & Extremities

649.00M(10.53%)

608.00M(10.46%)

564.00M(10.16%)

543.00M(10.41%)

576.00M(11.05%)

460.00M(10.09%)

488.00M(9.50%)

493.00M(10.05%)

Arthroscopic Enabling Technologies

647.00M(10.50%)

632.00M(10.88%)

588.00M(10.60%)

567.00M(10.87%)

590.00M(11.32%)

517.00M(11.34%)

591.00M(11.50%)

600.00M(12.23%)

Hip Implants

641.00M(10.40%)

619.00M(10.65%)

599.00M(10.79%)

584.00M(11.20%)

612.00M(11.74%)

567.00M(12.43%)

613.00M(11.93%)

613.00M(12.50%)

Advanced Wound Bioactives

621.00M(10.07%)

581.00M(10.00%)

553.00M(9.97%)

520.00M(9.97%)

496.00M(9.52%)

431.00M(9.45%)

424.00M(8.25%)

320.00M(6.53%)

Advanced Wound Devices

406.00M(6.59%)

365.00M(6.28%)

328.00M(5.91%)

280.00M(5.37%)

269.00M(5.16%)

232.00M(5.09%)

242.00M(4.71%)

215.00M(4.38%)

ENT (Ear, Nose and Throat)

220.00M(3.57%)

210.00M(3.61%)

196.00M(3.53%)

153.00M(2.93%)

131.00M(2.51%)

106.00M(2.32%)

151.00M(2.94%)

--(--)

Other Surgical Businesses

136.00M(2.21%)

131.00M(2.25%)

111.00M(2.00%)

87.00M(1.67%)

92.00M(1.77%)

68.00M(1.49%)

79.00M(1.54%)

209.00M(4.26%)

Theo Khu vực

Doanh thu

Tỷ trọng

Hàng năm

Hàng năm

Hàng quý

United States of America

Other Established Markets

Emerging &internatiuonal market

United Kingdom

China

Other

Established Markets

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States of America

3.31B(53.63%)

3.12B(53.75%)

2.98B(53.69%)

2.76B(53.00%)

2.66B(51.00%)

2.34B(51.29%)

2.55B(49.65%)

2.35B(48.00%)

2.33B(48.94%)

2.30B(49.24%)

2.22B(47.84%)

2.01B(43.58%)

1.86B(42.79%)

1.65B(39.91%)

1.76B(41.12%)

Other Established Markets

1.48B(24.03%)

1.27B(21.88%)

1.14B(20.45%)

999.00M(19.16%)

1.10B(21.05%)

966.00M(21.18%)

1.08B(21.08%)

1.48B(30.22%)

--(--)

1.71B(41.24%)

1.77B(41.43%)

Emerging &internatiuonal market

1.00B(16.27%)

980.00M(16.87%)

959.00M(17.28%)

947.00M(18.16%)

916.00M(17.57%)

771.00M(16.91%)

957.00M(18.63%)

857.00M(17.48%)

--(--)

677.00M(14.66%)

563.00M(12.94%)

483.00M(11.68%)

454.00M(10.63%)

United Kingdom

246.00M(3.99%)

226.00M(3.89%)

201.00M(3.62%)

186.00M(3.57%)

189.00M(3.63%)

166.00M(3.64%)

211.00M(4.11%)

211.00M(4.30%)

244.00M(5.12%)

266.00M(5.70%)

301.00M(6.50%)

299.00M(6.48%)

293.00M(6.73%)

297.00M(7.18%)

291.00M(6.81%)

China

128.00M(2.08%)

210.00M(3.61%)

275.00M(4.96%)

319.00M(6.12%)

352.00M(6.75%)

318.00M(6.97%)

336.00M(6.54%)

--(--)

Other

--(--)

2.19B(45.94%)

2.10B(45.06%)

2.12B(45.66%)

--(--)

Established Markets

--(--)

1.63B(35.28%)

1.63B(37.53%)

--(--)